ThomasNet Home   |   Promote Your Business
Home  |   My ThomasNet News®  |   Industry Market Trends  |   Submit Release  |   Advertise  |   About Us May 25, 2012  

Lucid Appoints Dr. Clifford Perlis as U.S. Medical Director

Print | 
Email |  Comment   Share  

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

Lucid Inc.
2320 Brighton-Henrietta
Rochester, NY, 14623
USA



Press release date: September 5, 2007

ROCHESTER, NEW YORK, USA - September 5, 2007 - Lucid, Inc., a leading U.S. cellular imaging and technology company, today announced the appointment of Clifford Perlis, M.D., M.Be., as the new U.S. Medical Director. He is currently the Director of Mohs Surgery in the Department of Medical Oncology at Fox Chase Cancer Center in Philadelphia.

In the newly created position at Lucid, Dr. Perlis will play a key role in the direction of Lucid's clinical and medical research programs, support medical training and marketing initiatives, and aid in the submission of IRB protocols to third party organizations.

Dr. Perlis received his M.D. degree from the University of Pennsylvania School of Medicine in Philadelphia, and also holds a Masters in Bioethics from the University of Pennsylvania.

"Lucid is an innovative and dynamic company with a broad technology portfolio in the medical imaging and information fields. The company plans to initially apply these innovative imaging technologies in the field of dermatology, allowing my peers to attain a level of diagnostic capability similar to that radiologists routinely achieve using MRI and CT scans of the body. Ultimately, Lucid's confocal imaging technology will be applied in numerous other medical technologies," said Dr. Perlis.

Lucid is the creator of the non-invasive VivaScopeŽ confocal microscope that provides cellular resolution images of skin, and of the VivaNet(TM), an Internet-based, DICOM-compliant medical information system that enables the transfer of VivaScopeŽ digital images between practitioners and pathologists for rapid review of confocal images.

"As Lucid moves toward the launch of its clinical applications for VivaScopes and the VivaNet, it is important to have a voice on our management team that can express the needs of physicians and patients to our Board of Directors and the company's outside stakeholders. Dr. Clifford Perlis, a practicing dermatologic surgeon with degrees in medicine and bioethics, is very well suited to this role. I look forward to working with Dr. Perlis as we move Lucid's unique technologies into routine medical practice around the world," said Jay Eastman, Chairman and CEO of Lucid, Inc.

About Lucid Inc.

Lucid, Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScopeŽ cellular resolution images to medical professionals. When coupled with its digital VivaNet(TM) system, the company's ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit www.lucid-tech.com or call +1-585-239-9800.
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


User comments about this story

U.S.MEDICAL DIRECTOR

GREAT SELECTION FOR THIS POSITION. DR. PERLIS IS PROFESSIONAL, CARING, KNOWLEGABLE AND EXPERT IN THIS FIELD. I AM A MENTAL HEALTH RN AS WELL AS HIS PATIENT. THANK GOD FOR DEDICATED DOCTORS LIKE HIM.

By JANET A. GARDNER, RN,BC on Sep 18, 2009 10:19

Reply to this comment


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



Start Your Free
Subscription to
Industry Market Trends.
 More New Product News from this company:
Server promotes collaboration in dermatology applications.
More ....
 Other News from this company:
Lucid Receives FDA Clearance to Market Its VivaScopeŽ Reflective Confocal Microscope System in the U.S.
Lucid's VivaScopeŽ Reflective Confocal Microscope Approved for Sale in China
William Shea Elected as Chairman of Lucid, Inc.
Lucid Initiates Association of VivaScope Confocal Diagnostic Readers in Europe
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story


Home  |  My ThomasNet News®  |  Industry Market Trends  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2012 Thomas Publishing Company
Terms of Use - Privacy Policy



Error close

Please enter a valid email address